PRIVIGEN
For the treatment of:
Primary humoral immunodeficiency (PI)
Chronic immune thrombocytopenic purpura (ITP) in patients age 15 years and older
Chronic inflammatory demyelinating polyneuropathy (CIDP) in adults
Recommend0 recommendationsPublished in US National Health Agency Sources